Conference call interim report
Invitation to attend Vitrolife's conference call regarding presentation of the
interim report for the period January-March 2008. The presentation will be held
in Swedish.
Time: Monday, April 28, 2008 at 3.00 p.m. CET.
Telephone number: +46 8 505 201 10
Conference name: Vitrolife
Vitrolife participants:
Magnus Nilsson, CEO
Anna Ahlberg, CFO
The press release for Vitrolife's interim report will be released in good time
before 3.00 p.m. CET on April 28.
Before the conference call, slides will be available at the company web page,
www.vitrolife.com, under the section Investors/News (the Swedish page).
A recorded version of the presentation will be available for seven days on
number +46 8 505 203 33, access code 793407.
Queries should be addressed to:
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.
________________________________________________________________________________
_________
Vitrolife is a global biotechnology/medical device Group that works with
developing, manufacturing and selling advanced products and systems for the
preparation, cultivation and storage of human cells, tissue and organs. The
company has business activities within three product areas: Fertility,
Transplantation and Stem Cell Cultivation. The Fertility product area works with
nutrient solutions (media) and advanced consumable instruments such as needles
and pipettes, for the treatment of human infertility. The Transplantation
product area works with solutions and systems to maintain tissue in optimal
condition outside the body for the required time while waiting for
transplantation. The Stem Cell Cultivation product area works with media and
instruments to enable the use and handling of stem cells for therapeutic
purposes.
Vitrolife today has approximately 140 employees and the company's products
are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and
there are subsidiaries in Sweden, USA, Australia and Italy. The Vitrolife share
is listed on the OMX Nordic Exchange Stockholm's Nordic Small Cap list.
________________________________________________________________________________
_________
Vitrolife AB (publ), Faktorvägen 13, SE-434 37 Kungsbacka, Sweden. Corporate
identity number 556354-3452.
Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com.
Homepage: www.vitrolife.com.
This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.
Conference call interim report
| Source: Vitrolife AB
Attachments
